The Strategist: Beatrix Szebeni-Varga
By
Our Expert on Quality and Regulatory Compliance
New Article in Major Journal Highlights Flaws in American Circumcision Policy
The need for transparency on non-medical factors in circumcision policy.
Healing the Harm, Restoring Wholeness
Insights From Our White Paper
November 1st, 2025
Rat trial results are published! Plus: Final safety testing is nearing completion in the lab
October 1st, 2025
Promising Biocompatibility Results
September 2nd, 2025
Foregen moves towards milestone 4, launches lab tour video, and seeks institutional funding.
May 13th, 2022
Newsletter
There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 3)
Animal Model
April 12th, 2022
There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 2)
March 12th, 2022
There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 1)
February 10th, 2022
Rat Model Overview
Animal Trials
A Year in Review: 2021
Looking Back
Commentarium
by foregen